Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2003
10/02/2003CA2480049A1 Novel polypeptide scaffolds and use thereof
10/02/2003CA2480034A1 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003CA2479908A1 Calcineurin activator
10/02/2003CA2479907A1 P-rex1, a ptdins (3, 4, 5) p3- g-beta-gamma-regulated guanine-nucleotide exchange factor for rac
10/02/2003CA2479896A1 A mutated immunoglobulin-binding protein
10/02/2003CA2479879A1 Neisseria mutants, lipooligosaccharides and immunogenic compositions
10/02/2003CA2479769A1 Novel bacillus thuringiensis insecticidal proteins
10/02/2003CA2479732A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003CA2479731A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003CA2479730A1 Novel compositions and methods in cancer
10/02/2003CA2479727A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003CA2479723A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
10/02/2003CA2479721A1 Novel compositions and methods in cancer associated with altered expression of prlr
10/02/2003CA2479719A1 Novel compositions and methods in cancer associated with altered expression of mcm3ap
10/02/2003CA2479576A1 Antibody that binds to a dimer of a prion protein for the treatment of tse infection
10/02/2003CA2479306A1 Egfr ligands and methods of use
10/02/2003CA2479158A1 Recombinant expression vectors for functional nav1.9 sodium channels
10/02/2003CA2478839A1 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003CA2478063A1 Lymphatic and blood endothelial cell genes
10/02/2003CA2477812A1 A non-selective cation channel in neural cells and methods for treating brain swelling
10/02/2003CA2456955A1 Novel nucleic acids and secreted polypeptides
10/01/2003EP1348768A2 Method of treatment, diagnosis or detection of diabetes
10/01/2003EP1348758A1 Host cells having improved cell survival properties and methods to generate such cells
10/01/2003EP1348714A1 Polypeptide useful as anti-allergic/antiasthmatic, methods for the preparation thereof and pharmaceutical compositions containing such polypeptide and their use
10/01/2003EP1348335A1 Non-human transgenic mammals and their use as a disease model
10/01/2003EP1348036A2 Protection against mycobacterial infections
10/01/2003EP1348029A2 Materials and methods relating to protein aggregation in neurodegenerative disease
10/01/2003EP1348028A2 Substrate linked directed evolution (slide)
10/01/2003EP1348027A2 Gene disruption methodologies for drug target discovery
10/01/2003EP1348026A2 Fibrin binding moieties useful as imaging agents
10/01/2003EP1347993A2 Superficial zone protein and methods of making and using same
10/01/2003EP1347992A2 Polymorphic bone morphogenetic protein 2
10/01/2003EP1347991A2 Amphipathic peptides and their use for transferring substances of interest into cells
10/01/2003EP1347985A2 Biotin derivatives, methods for making same and uses thereof as vectors
10/01/2003EP1347953A2 Agents and methods for promoting bone growth
10/01/2003EP1347771A2 Methods of using imxp-888 and imxp-888 antagonists
10/01/2003EP1347770A2 Method of making a protein polymer and uses of the polymer
10/01/2003EP1100830B1 Heterominibodies
10/01/2003EP0946589B1 Inhibitors of peptide binding to mhc class ii proteins
10/01/2003EP0935755B1 Method for determining an increased chance of mortality
10/01/2003EP0783511B1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof
10/01/2003EP0662087B1 Method for purifying retinal pigmented epithelium derived neurotrophic factor
10/01/2003EP0638172B1 Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein
10/01/2003CN1446265A Means and method for monitoring antiretroviral therapy and guiding therapeutic decisions in treatment of HIV/AIDS
10/01/2003CN1446261A Modified cytokines for use in cancer therapy
10/01/2003CN1446260A Lipoxygenase genes, promoters, transit peptides and protein thereof
10/01/2003CN1446259A Nucleotide sequences which code for lysR2 gene
10/01/2003CN1446230A Peptide and peptide mimetic derivatives with integrin inhibitor preperties Ôàí"
10/01/2003CN1446229A Somatostatin analogues
10/01/2003CN1446228A 校正基因 Correction gene
10/01/2003CN1446227A Novel fibroblast growth factor (FRF23) and method for use
10/01/2003CN1446226A New nucleotide equences coding for lysR1 gene
10/01/2003CN1446102A Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens
10/01/2003CN1446098A Modulation of alpha-6 integrin-mediated responses
10/01/2003CN1446094A Method for obtaining antigenic structures enhancing specific cross reactivity
10/01/2003CN1445240A Killer cell antibiosis polypeptide activated by lymphokine and its application
10/01/2003CN1445239A Mutain of human stem cell growth fcator as well as its preparing method and medicine combination
10/01/2003CN1445238A Conformation type peptide library based on insect alexins, its constitute method and application
10/01/2003CN1445236A Oligopeptides for promoting hair growing
10/01/2003CN1444992A Method and combination for treating tumors based on ERBB-3
10/01/2003CN1444991A Preparing method and usage of cardiotoxin
10/01/2003CN1122719C Modified biological material
10/01/2003CN1122718C Botulinum toxin derivatives able to modify peripheral sensory afferent functions
10/01/2003CN1122716C Extracorporeal ceel culture and transplantation kits
10/01/2003CN1122532C Pigment marked protein composite and its preparing method
09/2003
09/30/2003US6627799 Genetic engineered cells having ability to adjust to environment and have plant disease resistance; hybrids
09/30/2003US6627796 Increasing the Rar1 concentration in the composition of plant to increase their resistance to plant diseases; recombinant expression cassettes; host cells; transgenic plants; crops
09/30/2003US6627793 Low temperature-inducible wheat WCS120 gene promoter
09/30/2003US6627747 Essential bacterial genes and their use
09/30/2003US6627746 DNA comprising nucleotide sequences that code for somatomedins and peptide domains
09/30/2003US6627745 Pyrin gene and mutants thereof, which cause familial Mediterranean fever
09/30/2003US6627744 Synthesis of glycodendrimer reagents
09/30/2003US6627741 Isolated antibody or fragment thereof that specifically binds to a protein with a specified amino acid sequence, as well as a hybridoma encoding it
09/30/2003US6627740 Monoclonol antibody which binds to a polypeptide having pre-B cell growth supporting ability
09/30/2003US6627738 No-modified hemoglobins and uses therefor
09/30/2003US6627736 Pap mutants that exhibit anti-viral and/or anti-fungal activity in plants
09/30/2003US6627735 Islet cell antigen 1851
09/30/2003US6627734 Given amino acid sequence, expression vectors; regulation of the KOR-3 splice variant activities may impact analgesia and weight management
09/30/2003US6627733 Receptor tyrosine kinase with a discoidin-type binding domain
09/30/2003US6627731 Thrombin derived polypeptides; compositions and methods for use
09/30/2003US6627730 Of given amino acid sequence, and diagnostic test kit; multidrug resistance
09/30/2003US6627729 TML peptides
09/30/2003US6627728 BASB010 polypeptides; fusion proteins; use in vaccines against bacterial infections including otitis media; related by sequence homology to TlyC hemolysin protein of Serpulina hyodysenteriae
09/30/2003US6627617 Temperature-sensitive regulation of viral vector production
09/30/2003US6627615 Methods and compositions for in vivo gene therapy
09/30/2003US6627610 Treat a viral infection in a subject via inhibiting the prenylation of a protein contained in the virus infecting said subject, which method comprises administering to said subject an agent selected from the group consisting of amino
09/30/2003US6627605 Polynucleotides which encode them, and methods for their use. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention further provides methods for diagnosing or treating disorders with
09/30/2003US6627601 Amino acid sequences derived partially from ependymin that binds with calcium; stroke and other neurodegenerative diseases; antiischemic agents; cognition activators; conjugated to transfer through blood-brain barrier
09/30/2003US6627458 Nuclear envelope protein for use in the diagnosis of autoimmune disorders
09/30/2003US6627449 Fluorescent protein sensors for measuring the pH of a biological sample
09/30/2003US6627440 Recombinant human alpha-fetoprotein as a cell proliferative agent
09/30/2003US6627438 Nucleotide sequences for use in the generation of amidated peptides
09/30/2003US6627437 GBV sequence
09/30/2003US6627415 Isolated nucleic acid comprising a nucleotide sequence encoding fibrinogen-like domain; use in diagnosis and treatment of tumor angiogenesis, wound healing, thromboembolic diseases, atherosclerosis and inflammationinflammation
09/30/2003US6627414 Genetic engineering; overlapping Dna sequences
09/30/2003US6627405 53BP2 complexes
09/30/2003US6627401 Method for detecting a single nucleotide polymorphism in p21waf1/cip1 gene as an indicator of risk of esophageal cancer
09/30/2003US6627395 Methods for the propagation, isolation, identification, and preparation of human immunodeficiency virus type 1 (HIV-1)
09/30/2003US6627204 Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses
09/30/2003US6627203 Non-virulent culture of Arthrobacter
1 ... 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 ... 2916